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Background: Severe anaemia due to dyserythropoiesis has been documented in patients infected with
Plasmodium vivax, however the mechanism responsible for anaemia in vivax malaria is poorly understood. In order
to better understand the role of P. vivax infection in anaemia the inhibition of erythropoiesis using haematopoietic
stem cells was investigated.
Methods: Haematopoietic stem cells/CD34+ cells, isolated from normal human cord blood were used to generate
growing erythroid cells. Exposure of CD34+ cells and growing erythroid cells to P. vivax parasites either from intact
or lysed infected erythrocytes (IE) was examined for the effect on inhibition of cell development compared with
untreated controls.
Results: Both lysed and intact infected erythrocytes significantly inhibited erythroid growth. The reduction of
erythroid growth did not differ significantly between exposure to intact and lysed IE and the mean growth relative
to unexposed controls was 59.4 ± 5.2 for lysed IE and 57 ± 8.5% for intact IE. Interestingly, CD34+ cells/erythroid
progenitor cells were susceptible to the inhibitory effect of P. vivax on cell expansion. Exposure to P. vivax also
inhibited erythroid development, as determined by the reduced expression of glycophorin A (28.1%) and CD 71
(43.9%). Moreover, vivax parasites perturbed the division of erythroid cells, as measured by the Cytokinesis Block
Proliferation Index, which was reduced to 1.35 ± 0.05 (P-value< 0.01) from a value of 2.08 ± 0.07 in controls. Neither
TNF-a nor IFN-g was detected in the culture medium of erythroid cells treated with P. vivax, indicating that
impaired erythropoiesis was independent of these cytokines.
Conclusions: This study shows for the first time that P. vivax parasites inhibit erythroid development leading to
ineffective erythropoiesis and highlights the potential of P. vivax to cause severe anaemia.
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Anaemia has frequently been associated with severe mal-
aria and is believed to contribute to the morbidity and
mortality of this disease. Most published reports on mal-
aria-associated anaemia focus on Plasmodium falcip-
arum with Plasmodium vivax being less well studied [1].
However, growing evidence from several geographic
regions has demonstrated that P. vivax malaria is asso-
ciated with a higher frequency and more severe anaemia
[2-12]. Several cases of patients infected with P. vivax* Correspondence: tasanee_p@yahoo.com
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distribution, and reproduction in any mediumthat resulted in severe disease and death were found to
have syndromes resembling those commonly observed
with falciparum malaria [8,13,14]. Although the under-
lying causes of severe malarial anaemia are multifactor-
ial, major causes are the destruction of parasitized
erythrocytes and ineffective erythropoiesis or dyserythro-
poiesis. In vivax malaria patients with anaemia red cells
in blood film are usually normochromic and normocytic
with the absolute reticulocyte count not elevated [15].
However, changes in haemoglobin concentrations are
associated with continuing parasitaemia during infection
of P. vivax in patients with anaemia [6]. In addition,
P. vivax has been observed in the bone marrow of
patients who exhibited dyserythropoiesis [15] and onetral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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cytopaenia in blood and bone marrow [16]. Investigation
by light and electron microscopy of marrow aspirates
from four Thai patients with P. vivax malaria and an-
aemic symptoms revealed morphological evidence of
dyserythropoiesis and the presence of erythroblasts at
various stages of degradation within the cytoplasm of
macrophages [17]. It seems likely that vivax malaria in-
fection was associated with an activation of the pro-in-
flammatory response and cytokine imbalance [18] and
experimental findings in mice are consistent with a role
for TNF-a in the dyserythropoietic changes in malaria
[19]. Other mechanisms have also been suggested, in-
cluding alterations in IFN-g, IL-12, IL-6, IL-1, reactive
oxygen species, nitric oxide, macrophage dysfunction, or
a direct effect of parasites (or parasite products) on the
bone marrow [15,20-22]. However, the mechanism re-
sponsible for anaemia in vivax malaria remains poorly
understood. Here, haematopoietic stem cells (HSCs)/
CD34+ from normal human cord blood were used to
generate growing erythroid cells (gEC) to investigate the
effect of P. vivax infection on erythropoiesis. Enhancing
the understanding of the pathogenesis of anaemia caused
by malaria is a prerequisite for developing effective pre-
vention and treatment strategies.
Methods
Collection and separation of Plasmodium vivax parasites
Plasmodium vivax was obtained from patients attending
the malaria clinic in Mae Sot, Tak Province, Thailand.
Patient blood with 0.1-0.3% parasitaemia, as determined
by examining thick and thin blood smears, was collected.
The ethical and methodological aspects of this study for
parasite collection (MU-IRB 2010/344.1612) have been
approved by the Mahidol University Institutional Review
Board, Mahidol University, Bangkok, Thailand. Infected
erythrocytes (IE) were separated from patient blood using
a 60% Percoll solution as previously described [23].
Briefly, whole blood with vivax parasites was collected
and then filtrated using a Plasmodipur filter (Euro-Diag-
nostic B.V., Netherlands) to remove white blood cells. To
obtain asexual parasites, packed, infected RBCs from
20 ml of patient blood was diluted 1:2 with RPMI1640
(InvitrogenW, CA, USA), layered on 60% Percoll and cen-
trifuged at 1,200 g for 20 mins at 20°C. The purity of IE
after isolation was 95% and the pure fraction of isolated
IE contained 80% schizontes and 20% of other stages.
The isolated IEs were used either intact or as lysed cells
prepared by freezing and thawing.
Isolation of cord blood CD 34+ cells and culture
conditions
Umbilical cord blood from normal full-term deliveries in
Ramathibodi Hospital, Bangkok, Thailand was collectedinto cord blood bags containing anticoagulant solution
(CPDA-1 solution) (Kawasumi Laboratories, Thailand).
Cord blood collection (ID 04-45-16) was approved by
the Ethical Committee of Research on Human Beings of
the Ramathibodi Hospital, Faculty of Medicine, Mahidol
University. Haematopoietic stem cells/CD34+ cells were
isolated from cord blood mononuclear cells (MNC)
using a CD 34 isolation kit with magnetic microbead
selection with Mini-MACS columns (Miltenyi Biotech,
Geramany) as described by Panichakul et al [23]. The
purity of CD34+ cells after isolation was 97% as judged
by flow cytometry analysis.
HSCs/CD34+ cells at a density of 1 × 105 cell/well in
24-well tissue culture plates (Corning Incorporated
CostarW, NY, USA) were cultured in 0.5 ml of complete
medium containing StemlineII medium (Sigma-Aldrich
Corporation, Missouri, USA) supplemented with cyto-
kines [23]. IE at the indicated concentration were added
to cell cultures on days 1, 5, 8 and 11 and cultured for
three additional days. Intact and lysed IE from the same
patients were utilized in this study. Recombinant human
tumour necrosis factor-alpha (TNF-a), human interferon
gamma (IFN-g) (Prospec-Tany TechnoGene Ltd., Reho-
vot, Israel), and uninfected erythrocytes (UE) from nor-
mal donor blood were included in this study. All
cultures were incubated at 37°C in 5% CO2 and viable
cells were determined by trypan blue dye exclusion.
Detection of surface markers of erythroid cells
Cell surface markers were detected using immunofluor-
escence with mouse antibodies to human CD34 (Milte-
nyi Biotech), CD71, CD45 (eBioscience, Inc. CA, USA)
and glycophorin A (Serotec Inc., NC, USA) to confirm
cell types of HSC and derived erythroid cells. Cells (5–
10 × 104 cells in 100 μl of medium) were stained with
5 μl of each antibody for 30 min at 4°C. After washing
twice with phosphate-buffer saline, stained cells were
fixed with 1% paraformaldehyde. Cell death was also
determined by staining with 20 μg/ml of propidium iod-
ide (BenderMedSystemsW, GmSH). All cell markers were
analysed by flow cytometry using an Epics XL-MCL ana-
lyser (Beckman Coulter, Inc. CA, USA).
Determination of inflammatory cytokines
The presence of inflammatory cytokines TNF-a and
IFN-g in culture medium of gEC was determined using
the Bio-Plex Pro™ Magnetic Cytokine assay (Bio-Rad La-
boratories, Inc. CA, USA). Briefly, 50 μl of beads coated
with different anti-cytokine antibodies were added to a
pre-wet filter plate and after washing 50 μl of culture
medium or cytokine standards were added to duplicate
wells and incubated for 30 min at room temperature in
the dark. The plate was washed three times with wash-
ing buffer and 50 μl of streptavidin-PE was added and
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washes, 125 μl of assay buffer was added and the plate
was analysed immediately using an array reader (Bio-
Plex Manager 5.0 Software, Bio-Rad Laboratories).Cell division assay
Five-day old cells were exposed to lysed IE for three days
followed by incubation with 3 μg/ml cytochalasin B
(Sigma-Aldrich Corporation) for 24 h as previously
described [24]. Cells (5–10 x 104 in 100 μl of medium)
were spun onto a slide using cytospin (Cytospin 3,
Thermo Shandon, UK) at 800 rpm for 10 min then fixed
with 95% ethanol for 10 min. Thereafter, cells were
stained for 10 min with Giemsa, then washed and dried.
Stained cells were examined under a light microscope
(Olympus BX50, Japan) and the proportion of mono-,
bi-, tri- and tetranucleated cells was evaluated in samples
of 2,000 cells. The Cytokinesis Block Proliferation Index
(CBPI) was calculated using the formula CBPI =X
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Figure 1 Effect of P. vivax on cell growth. (a) Lysates of infected erythr
and intact IEs or UEs were added in varying ratios of IE numbers to one
evaluated on day 8. The mean of erythroid growth (shown in bar graphs
lysate. 25 ng/ml of TNF-a was used as a positive control. The error bars s
with medium control.are the number of cells with one, two and three nuclei
(N), respectively [25].Statistical evaluation
Data were analysed using the SPSS program (version
11.0). The unpaired Mann–Whitney - Wilcoxon test was
used to compare means between independent groups as
appropriate and for statistical evaluation of CBPI.
Results are reported as statistically significant if the P-
value was less than 0.01.Results
Inhibition of cell growth by Plasmodium vivax
Growing erythroid cells (gEC) derived from human cord
blood HSCs/CD34+ cells were used as an in vitro model
for studying changes in erythropoiesis caused by P. vivax
infection. Infected erythrocytes (IE) were isolated from
the blood of malaria patients and the effect of the pres-
ence of IE on erythroid growth was determined as
shown in Figure 1a. The effect of lysates from IE was                       0.1     1     10    20     30 per gEC
                 UE
  Intact       IE              UE
                     0.1    1    10    0.1   1     10 per gEC 
ocytes (IE) or uninfected erythrocytes (UE) and (b) lysed IEs or UEs
growing erythroid cells (gEC) on day 5. Erythroid growth was
) was compared with a control containing medium without IE or UE
how the S.D. of 5 independent experiments, P-value< 0.01 compared
Panichakul et al. Malaria Journal 2012, 11:173 Page 4 of 8
http://www.malariajournal.com/content/11/1/173compared with those from uninfected erythrocytes (UE)
on gEC cultures by treating cells on day-5 with five
ratios of IE/UE: gEC (0.1:1, 1:1, 10:1, 20:1 and 30:1).
After culturing gEC for another three days, parasite-
induced inhibition of erythroid growth was monitored
and ratios as low as 1 lysed IE to 1 gEC were found to
cause a dose-dependent decrease in growth (Figure 1a).
The effect of lysed and intact IE on erythroid growth
was evaluated and is shown in Figure 1b. Lysed and in-
tact IE or UE were added on day 5 of gEC cultures and
their effects on day 8 were compared. Both lysed and in-
tact IE at a IE : gEC ratio of 10:1 significantly inhibited
the erythroid growth however addition of UE did not
alter growth. The reduction of erythroid growth did not
differ significantly between intact and lysed IE with the
mean growth relative to controls without lysed or intact
IE was 59.4 ± 5.2 for lysed IE and 57 ± 8.5% for intact IE.
These results demonstrated that there was no metabolic
effect of viable infected cells on erythroid cell growth.
Similar results were obtained with infected erythrocytes
from five different parasite isolates. Overall these results
demonstrate that lysed IE with low numbers of P. vivax-
infected cells are sufficient to inhibit the growth of
erythroid cells.
Inhibition of erythroid development
The inhibition of erythroid expansion and differentiation
by P. vivax was evaluated in the presence of IE and UE.
Lysed IE or UE were mixed with isolated CD34+ cells/
erythroid progenitor cells on day 1, 5, 8 and 11 after in-
duction of erythroid development. After three days,
lysed IE inhibited erythroid expansion, compared with
the controls (Table 1). The effect was greatest when a
ratio of 10 IE to one erythroid precursor was used on
day-1 resulting in reduction of erythroid growth to
43 ± 5.5% compared with controls without IE. The de-
gree of inhibition of erythroid expansion by IE on daysTable 1 Inhibition of erythroid expansion by lysate of





% of control (mean± S.D.)
IE IE UE UE TNF-a
1 10 1 10 25 ng/ml
1 67 ± 9.5* 43 ± 5.5* 100 ± 4.5 98 ± 5.5 54 ± 12*
5 72 ± 6.5* 58 ± 4.5* 99 ± 4.0 98 ± 4.8 69 ± 8*
8 88 ± 4.5 65 ± 7.5* 99 ± 2.0 99 ± 5.5 74 ± 7*
11 98 ± 8.5 87 ± 7.0* 100 ± 4.5 100 ± 5.0 78 ± 6*
* P-value< 0.01 compared with control wells.
Inhibition is presented as percentage of expansion of the control after three
day-culture without added medium, cells, or TNF-a. Lysates of infected
erythrocyte (IE) and uninfected erythrocyte (UE) were added at ratios of 1 or
10 IE / UE per 1 CD34+ cells / erythroid progenitor cells. The mean and S.D.
were calculated from five independent experiments.5, 8 and 11 was gradually decreased but still significant
(P-value< 0.01) indicating that CD34+/erythroid pro-
genitor cells were susceptible to the inhibitory effect of
P. vivax on cell expansion. The susceptibility to the in-
hibitory effect of P. vivax was decreased when cells were
mature as shown in Additional file 1. In addition, a re-
duction in erythroid cell development was supported by
the observed decrease in the expression of erythroblast
markers, 28.1% of glycophorin A and 43.9% of CD 71
after three days of culture with IE lysates compared to
controls without IE which expressed 50% of glycophorin
A and 72.1% of CD 71 (Figure 2a). Cell death was also
determined and found to occur at similar levels in cul-
tures with IE lysate (5.9 ± 1.2%) or media alone
(4.1 ± 1%), after three days of culture (Figure 2b). This
indicates that the reduction of erythroid cells when
exposed to IE lysates was not from death activation from
parasites but rather that parasites suppress erythropoiesis
through an inhibitory effect on expansion of CD34+/eryth-
roid progenitor cells.
Suppression of cell division by Plasmodium vivax
Cytokinesis Block Proliferation Index (CBPI) is a useful
parameter for assessing the inhibition of cell division in
cultures. To examine the inhibition of erythroid division
by P. vivax, lysed IE were added to five-day old gEC cul-
tures and after three days cell division was blocked by
cytochalasin B. In controls, treated with media or UE
lysates, large numbers of bi-nucleated cells were observed
with few tri- and tetra-nucleuated gEC. In contrast, cul-
tures exposed to IE lysates contained high numbers of
mono-nucleus gEC (Figure 3a). Cultures undergoing para-
site-suppression due to exposure with IE lysates displayed
a significant reduction (P-value< 0.01) in the CBPI
(1.35 ± 0.05; mean±S.D.) compared with gEC in media
control (2.08± 0.07) as shown in Figure 3b. The CBPI of
cultures treated with UE lysate and TNF-a were 2.0 ± 0.06
and 1.74± 0.04, respectively. These results suggest that
vivax parasites inhibited expansion of erythroid progenitor
cells by blocking cellular division.
In patients with vivax malaria, TNF-a and IFN-g have
been associated with malaria anaemia and may be
involved in promoting inadequate erythropoiesis. In this
model system, gEC cells were treated with recombinant
human TNF-a or IFN-g in various concentrations and
the erythroid cell growth was inhibited at TNF-a and
IFN-g concentrations 6.25 and 100 ng/ml, respectively
(Figure 4a). However, after adding lysed or intact IE to the
gEC cultures on day 5 endogenous TNF-a was undetect-
able after three days of parasite activation (Figure 4b),
even though the lower limit of detection in this assay
was 5 pg/ml. Another cytokine, IFN-g, was also un-
detectable in medium cultured with intact or lysed IE.
However, IFN-g could be detected in cultures treated
Figure 2 Determination of erythroid cell markers and death. gECs, five-days old were cultured with IE or UE lysate in the ratio 1:10. Cell
markers were determined after culturing for another three days by flow cytometry. (a) Dot-scatter graphs of erythroid cell markers, using
fluorescence-labelled anti-glycophorin A, CD 45 and CD 71 antibodies, and (b) cell death, using propidium iodide (PI) staining. The error bars of
histograms show the S.D. of three independent experiments.
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lower limit of IFN-g detection in this assay was 26 pg/
ml. Therefore, in this model, parasites inhibited eryth-
roid development in a way that was independent of
TNF-a and IFN-g.
Discussion
Numerous reports have shown that P. vivax can be
associated with severe anaemia [2-12]. Haematologic
profiles of pancytopaenia in blood and bone marrow
[16] and dyserythropoiesis in bone marrow [15] have
been reported in vivax malaria patients. However, the
cause of reduction in blood cell production in the bone
marrow of patients with vivax malaria is not completely
understood. Anaemia in malaria is caused by excessive
removal of non-parasitized erythrocytes, the immune
destruction of parasite-infected red cells, as well as by
the impaired compensation due to bone marrow dys-
function [1,15,17,26-28]. Plasmodium vivax requires
reticulocytes for expansion of the blood stages [29] andparasitaemia is generally low, therefore it is unlikely to
be the primary cause of anaemia [6]. This suggests that
in addition to the simple destruction of infected red
cells another mechanism is involved in anaemia in
vivax malaria.
Recently, the production of erythrocytes from the
in vitro cultures of haematopoietic stem cells was
achieved, as previously described [23] and this model is
now being applied to dissect the complexity of anaemia
in malaria. The results presented in this study have
revealed for the first time that P. vivax can directly
inhibited erythropoiesis, as shown by the reduction of
erythroid growth in the presence of either lysed or in-
tact IE. Erythroid progenitor cells were susceptible to
the inhibitory effect of P. vivax on cell expansion and
this result is consistent with the previous report that
young stages of erythroid cells were more susceptible
to P. vivax infection [23]. The suppression of erythro-
poiesis in malarial anaemia is not unique to P. vivax
and has also been observed in infections from other
Figure 3 Reduction of cell division by P. vivax. Five-day old
growing erythroid cells (gECs), 105 cells, in cultures with added
media, lysates of 106 infected cells (IE) or uninfected cells (UE) and
TNF-a were incubated for 72 h. (a) Cells stained with Giemsa, bi-
nucleuses in gECs are indicated with arrows, magnification X 1,000.
(b) CBPI (cytokinesis block proliferation index) of gEC cultures after
added cytochalasin B. The error bars represent the S.D. for five
independent experiments, *P-value< 0.01.
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falciparum infection, erythroid suppression is indicated
by a decrease in the number of erythroid precursors as
well as colony-forming units-erythroid (CFU-E) and
burst-forming units-erythroid (BFU-E) in the bone mar-
row cultures [30]. Plasmodium chabaudi can directly
suppress the proliferation, differentiation and matur-
ation of erythroid progenitor cells and causes inad-
equate reticulocytosis in mice [31]. However, deficient
erythropoietin production does not appear to be the
cause of inadequate erythropoiesis in malaria [32].Decreased responsiveness of erythroid progenitor cells
to erythropoietin as well as impaired erythropoietin pro-
duction mediated by inflammatory cytokines has been
reported to be involved in anaemia during inflammation
[33]. Consistent with this observation, TNF-a was
reported to partly inhibit proliferation of erythroid pro-
genitor cells in bone marrow cultures [34]. Erythroid
progenitor cells produced in this model were also sus-
ceptible to inhibition by exogenous TNF-a as shown in
Figure 4a. However, endogenous TNF-a and IFN-g in
erythroid cultures exposed to lysates or intact P. vivax
was undetectable (Figure 4b). This suggests that P. vivax
can also inhibit erythropoiesis independently of TNF-a
and IFN-g. Inhibition of erythroid development that is
independent of TNF-a and IFN-g has also been observed
by exposure with P. falciparum haemozoin [35,36].
However, other inflammatory cytokines may be involved
and high levels of IL-10 were found to correlate posi-
tively with inhibition of proliferative peripheral blood
mononuclear cells in the presence of P. falciparum hae-
mozoin [37]. In this study, IL-10 was also detectable in
supernatants from gECs in the presence of IEs and the
role of this cytokine in the inhibition of erythropoiesis
is currently being investigated. Interestingly, P. vivax
inhibited not only growth but also the differentiation of
erythroid progenitor cells as shown by the reduction of
glycophorin+ and CD 71+ cells and this is similar to the
inhibitory effect of P. falciparum haemozoin on eryth-
roid cell development [35,38]. Moreover, vivax parasites
were able to perturb the cell division but did not induce
the cell death of erythroid progenitor cells. Defects in
the cell cycle without apoptosis has also been observed
with the inhibitory effect of P. falciparum haemozoin
on erythroid cell growth [38]. It was found that falcip-
arum haemozoin-treated erythroid cells enhanced the
expression of the transcription factor p53 and cdk-in-
hibitor p21 in addition the retinoblastoma protein, a
central regulator of G- to S-phase transition was hypo-
phosphorylated, while GATA-1, the master transcription
factor in erythropoiesis was reduced [38]. Therefore the
molecular mechanisms underlying the suppression of
erythropoiesis by P. vivax or its products warrants fur-
ther investigation. The findings of this study are consist-
ent with the hypothesis that vivax parasites can suppress
erythropoiesis. These results provide a better under-
standing of the role of chronic and persistent P. vivax in-
fection as a cause of anaemia. Prolonged exposure to
vivax parasites can suppress erythropoiesis as well as in-
hibit reticulocyte production, which could prevent the
restoration of the erythrocyte population in chronic para-
sitaemic P. vivax infection. Many cases of patients with
severe anaemia have been reported in vivax endemic
areas in Thailand, Indonesian Papua, Korea, Pakistan,
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Figure 4 Effect of inflammatory cytokines on erythroid cell growth. (a) Growing erythroid cells (gECs) 5-days old were treated with
various concentrations of TNF-a (white bars) or IFN-g (grey bars) and cultured for an additional three days. * P< 0.01 compared with
medium control. (b) TNF-a (white bars) and IFN-g (grey bars) in erythroid culture activated by intact IEs or UEs; lysates of IEs or UEs; and
25 ng/ml of TNF-a as a positive control were determined using the Bio-Plex Pro™ Magnetic Cytokine assay. The error bars show the S.D.
from three independent experiments.
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and parasites have the potential to inhibit erythroid de-
velopment leading to ineffective erythropoiesis causing
severe anaemia.
Conclusions
This finding suggests that suppression of erythropoiesis
by P. vivax infection is potentially much more dangerous
than it is commonly believed and defective erythropoiesis
should be taken into consideration in the development of
therapeutic strategies to treat severe malarial anaemia.
Additional file
Additional file 1: Erythroid cell development. Giemsa staining of cells
from one to 11 day-old cultures showing CD34+ cells on day 1, and
morphological characteristic of erythroid cells with haemoglobin and
chromatin condensation for an orthochromic normoblasts (arrow) on day
11. Magnification X 1,000.
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